Nagi Bioscience
Latest round
- Series A
Last raised
- Jul 2023
Total raised
- $16M
Investors
- 7
About Nagi Bioscience
Founded in 2019, Nagi Bioscience SA is focused on developing advanced biological testing technologies.4 million.Nagi Bioscience specializes in high-content biological testing solutions, primarily through its flagship product, the SydLab™ One platform. This fully automated screening platform utilizes C. elegans nematodes to assess the effects of drugs and chemicals, enabling faster and more ethical biological testing. The platform is designed to enhance precision and reproducibility in research, making it particularly valuable for sectors focused on aging, neurodegenerative diseases, and safety toxicology.Nagi Bioscience operates primarily on a B2B model, generating revenue through partnerships and contract laboratory services. Clients, including pharmaceutical and biotechnology firms, engage with Nagi to access the SydLab™ One platform and its associated services, which include custom studies and high-throughput data generation. The transaction structure typically involves direct agreements with clients for the use of the platform on a project basis or through recurring contracts for ongoing research needs. The company is focused on launching new products and expanding into targeted markets within Europe and North America by 2024.
Who invested in Nagi Bioscience
7 investors across 2 rounds
See all investors in Nagi Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nagi Bioscience
Who invested in Nagi Bioscience?
Nagi Bioscience has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nagi Bioscience raised?
Nagi Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nagi Bioscience last raise money?
Nagi Bioscience's most recent round on record is a Series A, in Jul 2023.
What does Nagi Bioscience do?
Founded in 2019, Nagi Bioscience SA is focused on developing advanced biological testing technologies.
Where is Nagi Bioscience headquartered?
Nagi Bioscience is headquartered in Ecublens, Switzerland.
Which VCs invest in companies like Nagi Bioscience?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Nagi Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nagi Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.